Advances in drug treatment of retinal vein occlusion
Retinalvein occlusion(RVO)is the most common retinal vascular disease. The main causes of visual impairment and blindness are macular edema and retinal neovascularization. Drug therapies are the effective and safe method in the treatment of RVO currently. The main drugs conclude corticosteroid drugs...
| Main Authors: | , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Press of International Journal of Ophthalmology (IJO PRESS)
2017-11-01
|
| Series: | Guoji Yanke Zazhi |
| Subjects: | |
| Online Access: | http://ies.ijo.cn/cn_publish/2017/11/201711015.pdf |
| _version_ | 1818364996528111616 |
|---|---|
| author | Pan Long Yi-Bing Wu Jian Zhao Zuo-Ming Zhang Jing An |
| author_facet | Pan Long Yi-Bing Wu Jian Zhao Zuo-Ming Zhang Jing An |
| author_sort | Pan Long |
| collection | DOAJ |
| description | Retinalvein occlusion(RVO)is the most common retinal vascular disease. The main causes of visual impairment and blindness are macular edema and retinal neovascularization. Drug therapies are the effective and safe method in the treatment of RVO currently. The main drugs conclude corticosteroid drugs, anti-vascular endothelial growth factor drugs, thrombolytic drugs and traditional drugs. This article reviews the recent progress in RVO in order to provide some valuable references for clinical treatment. |
| first_indexed | 2024-12-13T22:13:15Z |
| format | Article |
| id | doaj.art-8906146c162b4c50b769992bc370e036 |
| institution | Directory Open Access Journal |
| issn | 1672-5123 1672-5123 |
| language | English |
| last_indexed | 2024-12-13T22:13:15Z |
| publishDate | 2017-11-01 |
| publisher | Press of International Journal of Ophthalmology (IJO PRESS) |
| record_format | Article |
| series | Guoji Yanke Zazhi |
| spelling | doaj.art-8906146c162b4c50b769992bc370e0362022-12-21T23:29:40ZengPress of International Journal of Ophthalmology (IJO PRESS)Guoji Yanke Zazhi1672-51231672-51232017-11-0117112055205910.3980/j.issn.1672-5123.2017.11.15Advances in drug treatment of retinal vein occlusionPan Long0Yi-Bing Wu1Jian Zhao2Zuo-Ming Zhang3Jing An4Department of Aerospace Clinical Medicine, Fourth Military Medical University, Xi'an 710032, Shaanxi Province, ChinaDepartment of Aerospace Clinical Medicine, Fourth Military Medical University, Xi'an 710032, Shaanxi Province, ChinaDepartment of Aerospace Clinical Medicine, Fourth Military Medical University, Xi'an 710032, Shaanxi Province, ChinaDepartment of Aerospace Clinical Medicine, Fourth Military Medical University, Xi'an 710032, Shaanxi Province, ChinaInstitute of Neurobiology, Xi'an Jiaotong University, Xi'an 710049, Shaanxi Province, ChinaRetinalvein occlusion(RVO)is the most common retinal vascular disease. The main causes of visual impairment and blindness are macular edema and retinal neovascularization. Drug therapies are the effective and safe method in the treatment of RVO currently. The main drugs conclude corticosteroid drugs, anti-vascular endothelial growth factor drugs, thrombolytic drugs and traditional drugs. This article reviews the recent progress in RVO in order to provide some valuable references for clinical treatment.http://ies.ijo.cn/cn_publish/2017/11/201711015.pdfretinal vein occlusiondrug therapyprogressprogress |
| spellingShingle | Pan Long Yi-Bing Wu Jian Zhao Zuo-Ming Zhang Jing An Advances in drug treatment of retinal vein occlusion Guoji Yanke Zazhi retinal vein occlusion drug therapy progress progress |
| title | Advances in drug treatment of retinal vein occlusion |
| title_full | Advances in drug treatment of retinal vein occlusion |
| title_fullStr | Advances in drug treatment of retinal vein occlusion |
| title_full_unstemmed | Advances in drug treatment of retinal vein occlusion |
| title_short | Advances in drug treatment of retinal vein occlusion |
| title_sort | advances in drug treatment of retinal vein occlusion |
| topic | retinal vein occlusion drug therapy progress progress |
| url | http://ies.ijo.cn/cn_publish/2017/11/201711015.pdf |
| work_keys_str_mv | AT panlong advancesindrugtreatmentofretinalveinocclusion AT yibingwu advancesindrugtreatmentofretinalveinocclusion AT jianzhao advancesindrugtreatmentofretinalveinocclusion AT zuomingzhang advancesindrugtreatmentofretinalveinocclusion AT jingan advancesindrugtreatmentofretinalveinocclusion |